Eaton Vance Tax Advantaged Dividend Income Fund (EVT) Actualités

Form 5 - Annual statement of changes in beneficial ownership of securities

Form 5 - Annual statement of changes in beneficial ownership of securities

Form 5 - Annual statement of changes in beneficial ownership of securities

Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

The following Eaton Vance closed-end funds (the “Funds”) announced distributions today as detailed below. Declaration – 11/1/2024 Ex-Date –...

Eaton Vance Closed-End Funds Release Estimated Sources of Distributions

The Eaton Vance closed-end funds listed below released today the estimated sources of their October distributions (each a “Fund”). This press...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

The following Eaton Vance closed-end funds (the “Funds”) announced distributions today as detailed below. Declaration – 10/1/2024 Ex-Date –...

Eaton Vance Closed-End Funds Release Estimated Sources of Distributions

The Eaton Vance closed-end funds listed below released today the estimated sources of their September distributions (each a “Fund”). This press...

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and X-Chem, leader in DNA-encoded library (DEL...

Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

The following Eaton Vance closed-end funds (the “Funds”) announced distributions today as detailed below. Declaration – 9/3/2024 Ex-Date –...

Eaton Vance Closed-End Funds Release Estimated Sources of Distributions

The Eaton Vance closed-end funds listed below released today the estimated sources of their August distributions (each a “Fund”). This press...

Form N-PX - Annual Report of proxy voting record of management investment companies

Form 4 - Statement of changes in beneficial ownership of securities